High serum levels of VEGF-A [7] and basic fibroblast growth factor [8] have been associated with poor clinical outcome in HCC [8], and VEGF-A polymorphisms have been associated with prognosis [9]. Here, VEGFA is linked to hepatocellular carcinoma.